COSTA MESA, Calif., June 1, 2026 /PRNewswire/ — CerraCap Impact Venture Capital (“CIVC”) today announced the appointment of Mark Rohrwasser, former Chief Information Officer of Silicon Valley Bank and Equifax, to lead its CXO Council. The CXO Council is a strategic executive advisory platform that brings together accomplished enterprise CXOs
Studies utilizing Gemelli’s proprietary diagnostic technologies demonstrate key clinical applications, advancements in IBS and SIBO diagnostics, and treatment support. These findings will be presented at Digestive Disease Week® 2026 (May 2-5), reflecting the increasing adoption of 3-gas breath and antibody testing. RALEIGH, N.C.–(BUSINESS WIRE)–Gemelli Biotech announced today that its diagnostic
COSTA MESA, Calif., April 21, 2026 /PRNewswire/ — CerraCap Ventures investment in Nephronomics reflects strategic conviction of backing platforms that transform fragmented healthcare systems into predictive, precision-driven ecosystems. Nephronomics is a next-generation AI-bio precision medicine company. The company is building one of the world’s most comprehensive clinical and genomic data
CerraCap Ventures and Impact Venture Capital announced their merger to form CerraCap Impact Venture Capital (CIVC). Based in Costa Mesa, CA, the combined firm brings together a network of corporate customers, corporate investors, and strategic acquirers, positioning CIVC as a partner for founders who need rapid commercial validation and scalable
Recent Comments